Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Hypha Labs (FUNI) EBITDA (2016 - 2025)

Hypha Labs filings provide 15 years of EBITDA readings, the most recent being -$490955.0 for Q3 2025.

  • On a quarterly basis, EBITDA rose 13.69% to -$490955.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.0 million, a 64.28% decrease, with the full-year FY2025 number at -$3.0 million, down 64.28% from a year prior.
  • EBITDA hit -$490955.0 in Q3 2025 for Hypha Labs, up from -$536027.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $2620.0 in Q1 2021 to a low of -$1.3 million in Q4 2024.
  • Median EBITDA over the past 5 years was -$280720.0 (2021), compared with a mean of -$355198.7.
  • Biggest five-year swings in EBITDA: surged 100.44% in 2021 and later crashed 11644.12% in 2022.
  • Hypha Labs' EBITDA stood at -$217590.0 in 2021, then skyrocketed by 50.67% to -$107336.0 in 2022, then soared by 34.26% to -$70564.0 in 2023, then crashed by 1749.76% to -$1.3 million in 2024, then surged by 62.39% to -$490955.0 in 2025.
  • The last three reported values for EBITDA were -$490955.0 (Q3 2025), -$536027.0 (Q2 2025), and -$669162.0 (Q1 2025) per Business Quant data.